Showing results 1 to 20 of 74
next >
| Issue Date | Title | Author(s) |
| 10-May-2024 | Advances in MET tyrosine kinase inhibitors in gastric cancer | Zhang, Yifan; Shen, Lin; Peng, Zhi |
| Sep-2021 | Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer | Wang, Yujiao; Jiao, Xi; Li, Shuang; Chen, Huan; Wei, Xin; Liu, Chang; Gong, Jifang; Zhang, Xiaotian; Wang, Xicheng; Peng, Zhi; Qi, Changsong; Wang, Zhenghang; Wang, Yanni; Zhuo, Na; Zou, Jianling; Zhang, Henghui; Li, Jian; Shen, Lin; Lu, Zhihao |
| 2013 | Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis | Peng, Zhi; Wang, Qianqian; Gao, Jing; Ji, Zhaoning; Yuan, Jiajia; Tian, Ye; Shen, Lin |
| 20-May-2020 | Association of HLA class I genotype with outcomes of gastrointestinal cancer patients with immunotherapy. | Lu, Zhihao; Shen, Lin; Zhang, Henghui; Jiao, Xi; Wang, Yujiao; Zhang, Lei; Qian, Juanjuan; Chen, Huan; Yang, Ying; Wu, Lijia; Liu, Chang; Gong, Jifang; Li, Jian; Zhang, Xiaotian; Wang, Xicheng; Peng, Zhi; Qi, Changsong; Wang, Zhenghang; Li, Yanyan |
| Aug-2020 | Association of lymphocyte-to-monocyte ratio and systemic inflammation index with survival in advanced gastric cancer patients treated with immune checkpoint inhibitor | Chen, Yang; Zhang, Cheng; Qi, Changsong; Peng, Zhi; Gong, Jifang; Zhang, Xiaotian; Li, Jian; Shen, Lin |
| 1-Jun-2021 | Association of Lymphocyte-to-Monocyte Ratio With Survival in Advanced Gastric Cancer Patients Treated With Immune Checkpoint Inhibitor | Chen, Yang; Zhang, Cheng; Peng, Zhi; Qi, Changsong; Gong, Jifang; Zhang, Xiaotian; Li, Jian; Shen, Lin |
| 2013 | Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients | Gao, Jing; Zhou, Jun; Li, Yanyan; Peng, Zhi; Li, Yilin; Wang, Xicheng; Shen, Lin |
| 2019 | Autophagy inhibition enhances PD-L1 expression in gastric cancer | Wang, Xiaojuan; Wu, William K. K.; Gao, Jing; Li, Zhongwu; Dong, Bin; Lin, Xiaoting; Li, Yilin; Li, Yanyan; Gong, Jifang; Qi, Changsong; Peng, Zhi; Yu, Jun; Shen, Lin |
| 2014 | Axitinib alone or in combination with chemotherapeutic drugs exerts potent antitumor activity against human gastric cancer cells in vitro and in vivo | He, Qiong; Gao, Jing; Ge, Sai; Wang, Tingting; Li, Yanyan; Peng, Zhi; Li, Yilin; Shen, Lin |
| 2019 | Camrelizumab combined with capecitabine and oxaliplatin followed by camrelizumab and apatinib as first-line therapy for advanced or metastatic gastric or gastroesophageal junction cancer: Updated results from a multicenter, open label phase II trial. | Shen, Lin; Peng, Zhi; Zhang, Yan-Qiao; Wei, Jia; Wang, Feng; Ying, Jieer; Deng, Yanhong; Gu, Kangsheng; Cheng, Ying; Yuan, Xianglin; Xiao, Juxiang; Wang, Linna; Zou, Jianjun |
| 1-Jun-2021 | Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction | Peng, Zhi; Wei, Jia; Wang, Feng; Ying, Jieer; Deng, Yanhong; Gu, Kangsheng; Cheng, Ying; Yuan, Xianglin; Xiao, Juxiang; Tai, Yanfei; Wang, Linna; Zou, Jianjun; Zhang, Yanqiao; Shen, Lin |
| 1-Feb-2020 | Change in neutrophial-to-lymphocyte ratio (NLR) in response to immune checkpoint inhibitor for advanced gastric cancer | Chen, Yang; Peng, Zhi; Gong, Jifang; Qi, Changsong; Zhang, Xiaotian; Li, Jian; Shen, Lin |
| Sep-2022 | The circadian clock sets a spatial-temporal window for recent thymic emigrants | Minaduola, Mili; Aili, Abudureyimujiang; Bao, Yuhui; Peng, Zhi; Ge, Qing; Jin, Rong |
| 1-Jun-2024 | Claudin18.2-targeted chimeric antigen receptor T cell-therapy for patients with gastrointestinal cancers: Final results of CT041-CG4006 phase 1 trial | Qi, Changsong; Liu, Chang; Gong, Jifang; Li, Jian; Liu, Dan; Wang, Xicheng; Zhang, Panpan; Qin, Yanru; Zhang, Miao; Peng, Zhi; Zhou, Jun; Zhang, Xiaotian; Peng, Xiaohui; Wang, Yumeng; Zhang, Zijing; Yuan, Daijing; Liu, Zhen; Baffa, Raffaele; Li, Zonghai; Shen, Lin |
| 2017 | Clinical features of patients with pancreatic neuroendocrine neoplasms: a retrospective analysis of 61 cases in a cancer center | Zhang, Panpan; Lu, Ming; Wang, Xicheng; Shen, Lin; Li, Jian; Zhou, Jun; Zhang, Xiaotian; Peng, Zhi; Cao, Yanshuo; Yang, Zuyao; Li, Jie |
| 23-Sep-2021 | Clinicopathological Characteristics and Response to Chemotherapy in Treatment-Naive Epstein-Barr Virus Associated Gastric Cancer: A Retrospective Study | Xie, Tong; Peng, Zhi; Liu, Yiqiang; Zhang, Zhening; Zhang, Xiaotian; Li, Jian; Lu, Ming; Gong, Jifang; Qi, Changsong; Ji, Jiafu; Shen, Lin |
| Jul-2021 | Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm | Zhang, Panpan; Li, Zhongwu; Li, Jie; Li, Jian; Zhang, Xiaotian; Lu, Zhihao; Sun, Yu; Li, Yan; Zhou, Jun; Wang, Xicheng; Peng, Zhi; Shen, Lin; Lu, Ming |
| Oct-2021 | Co-Expression with Membrane CMTM6/4 on Tumor Epithelium Enhances the Prediction Value of PD-L1 on Anti-PD-1/L1 Therapeutic Efficacy in Gastric Adenocarcinoma | Wang, Ziqi; Peng, Zhi; Liu, Qiyao; Guo, Zixia; Menatola, Merey; Su, Jing; Li, Ting; Ge, Qing; Wang, Pingzhang; Shen, Lin; Jin, Rong |
| 3-Mar-2023 | Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors | Zhang, Yifan; Cheng, Siyuan; Zou, Hua; Han, Zihan; Xie, Tong; Zhang, Bohan; Dai, Die; Yin, Xiaochen; Liang, Yong; Kou, Yan; Tan, Yan; Shen, Lin; Peng, Zhi |
| 13-Oct-2020 | Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China | Peng, Zhi; Hou, Xingduo; Huang, Yangmu; Xie, Tong; Hua, Xinyang |
